Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Boots could be spun out if Walgreens buyout goes ahead - report
(Sharecast News) - Chemist chain Boots could be put up for sale again should a possible takeover of its US parent go ahead, it was reported on Wednesday. The UK retailer is part of Walgreens Boots Alliance, which is understood to be in talks with US private equity firm Sycamore Partners, a specialist in retail assets.
Walgreens has around 12,500 outlets in the US, Europe and South America. But it has been rocked by high inflation and stiff competition, and slumped to a $8.6bn loss in the most recent fiscal year.
It has already announced plans to shut stores, but according to multiple media reports, including the Financial Times and Wall Street Journal, it is now in potential takeover talks with Sycamore.
The New York-listed retailer currently has a market value of around $8bn.
However, according to Sky News, Sycamore will likely spin off Boots if it succeeds in taking Walgreens private.
The 175-year Nottingham-based retailer, which has around 1,900 stores and employs 52,000 people, was acquired by Walgreens in 2014.
Previous owner Stefano Pessina, the veteran Italian dealmaker who orchestrated the sale to Walgreens, retains a 17% stake and is likely to be a potential bidder should it come to market, Sky News noted.
Pessina combined Boots with his own pharmacy business in 2006 to create Alliance Boots, before teaming up with US private equity firm KKK to take the then blue chip private. Walgreens took an initial 45% stake before buying Boots outright.
Private equity firms are also likely to be interested, however, including Apollo Global Management.
A number were understood to be interested in 2022, when Walgreens was last considering selling Boots. Apollo and India's Reliance Industries were understood to be putting together a possible £5bn joint offer when Walgreens terminated the sale process.
So far neither Pessina, Walgreens nor Sycamore have commented.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.